Choroidal melanoma in a 7-year-old child treated by trans-scleral local resection

Andrea Russo1, Sarah Ellen Coupland, Michael O'Keefe

  • 1St Paul's Eye Unit, Oncology Service, Royal Liverpool University Hospital, Liverpool, UK.

Insights

This study details the successful trans-scleral resection and brachytherapy for a pediatric choroidal melanoma, preserving the eye and vision. Genetic analysis indicated a favorable prognosis for the young patient.

Area of Science:

  • Ophthalmology
  • Pediatric Oncology
  • Genetics

Background:

  • Choroidal melanoma is rare in children.
  • Family history of neurofibromatosis type I (NF1) and melanoma present.
  • Differential diagnosis included neurilemmoma, leiomyoma, and neurofibroma.

Observation:

  • A 7-year-old child presented with a choroidal tumor.
  • Treatment involved trans-scleral local resection followed by adjuvant brachytherapy.
  • Histopathology confirmed amelanotic melanoma, spindle cell type, with 7 mitoses/40 HPF.

Findings:

  • Multiplex ligation-dependent probe amplification (MLPA) revealed favorable genetic markers (2 copies of chromosome 3, 3 copies of 6p, 2 copies of 8).
  • Postoperative evaluation at 6 months showed no residual tumor and a flat retina.
  • Visual acuity was 6/60, indicating good vision retention.

Implications:

  • Trans-scleral resection and brachytherapy are viable treatment options for pediatric choroidal melanoma.
  • Favorable cytogenetic findings can reassure families regarding prognosis.
  • Early detection and multimodal treatment can lead to successful outcomes in pediatric ocular tumors.
Abstract

Related Concept Videos